A Psychosocial Treatment Program for College Students (ACCESS) (ACCESS)

December 4, 2019 updated by: Arthur Anastopoulos, University of North Carolina, Greensboro

Improving the Educational and Social-Emotional Functioning of College Students With ADHD

The results of this study are expected to provide important and new information regarding the treatment of academic impairment among college students with ADHD. The present study should provide a substantial addition to the existing knowledge base concerning interventions for college students with ADHD. In addition, because the intervention is being implemented during college, potential benefits include the prevention of the severe academic and psychosocial functioning difficulties associated with ADHD, including school dropout.

Study Overview

Detailed Description

This proposal, "Improving the Educational and Social-Emotional Functioning of College Students with ADHD," was submitted in response to CFDA-84.305A Postsecondary and Adult Education Research, Goal 3 - Efficacy and Replication.

The number of young adults with Attention-Deficit/Hyperactivity Disorder (ADHD) pursuing college degrees has increased dramatically over the past 30 years. Students with ADHD currently represent one of the largest disability groups on college campuses, with at least 25% of all college students who receive disability services identified with ADHD. The need for such services is clearly warranted, given that college students with ADHD are at increased risk for having low and failing grades, being placed on academic probation, and ultimately dropping out of college. Currently, many colleges and universities offer students with ADHD extended time and other accommodations. Unfortunately, use of these accommodations is not empirically supported, presumably because they do not address the core difficulties - deficits in executive and psychological functioning - shown to lead to educational impairment in college students with ADHD. Further complicating matters is that systematic investigation of potentially useful psychosocial interventions for college students with ADHD has been lacking.

The investigators set out to address this gap by working with stakeholders to develop a psychosocial intervention for college students with ADHD, known as ACCESS - Accessing Campus Connections and Empowering Student Success. Development of ACCESS was guided by careful consideration of conceptual and empirical factors thought to contribute to the difficulties experienced by college students with ADHD, thus resulting in an intervention that specifically targets executive functioning, other core ADHD features, and psychological functioning. To date, a detailed treatment manual has been developed and revised through an iterative process. A large open trial of ACCESS was recently completed by one of the PIs and a second open trial of a similar intervention was independently completed by the other PI. These trials demonstrate the feasibility of delivering ACCESS on college campuses with fidelity and establish preliminary efficacy. In both trials, college students with ADHD made significant improvements in ADHD symptom severity, executive functioning, educational performance, and emotional functioning. Although promising, such findings are limited by the absence of control groups, thereby preventing firm conclusions about efficacy. Accordingly, the primary goal of this Goal 3 study is to conduct a multi-site randomized controlled trial to evaluate the efficacy of the ACCESS intervention and to assess moderators and mediators of intervention response.

College students with ADHD (N=240) from two large, diverse public universities were randomly assigned either to ACCESS or to a delayed treatment condition. Five cohorts of students were recruited, with each cohort consisting of 24 students from each site. Educational, executive, psychological, and social functioning, as well as service utilization, were assessed at pre-treatment, at the end of active intervention, at the end of the maintenance phase, and during a 6-month follow-up. An intent-to-treat analysis was used to assess the efficacy of ACCESS. Moderator and mediator analyses will also be conducted to address the types of students most likely to benefit from ACCESS and to evaluate key mechanisms of change that lead to improved academic and social-emotional functioning.

This study has significant potential to improve the performance of college students with ADHD because the intervention was specifically designed to address deficits in executive and psychological functioning, factors shown to predict the educational outcomes of college students with ADHD. Further, the ACCESS intervention was designed with stakeholder input and thus has clear potential for dissemination upon proof of efficacy.

Study Type

Interventional

Enrollment (Actual)

280

Phase

  • Not Applicable

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 30 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • voluntary consent
  • 18-30 years of age
  • DSM-5 criteria for ADHD
  • estimated IQ greater than 85

Exclusion Criteria:

  • co-occurring autism spectrum disorder, bipolar disorder, obsessive-compulsive disorder, and/or active substance abuse

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: Immediate Treatment
Cognitive-Behavioral Treatment program known as ACCESS
Cognitive-Behavioral Treatment delivered across 2 semesters via group and individual mentoring sessions
Other: Delayed Treatment
Allowed to receive treatment as usual during study, then received ACCESS after delay of two-semesters
Cognitive-Behavioral Treatment delivered across 2 semesters via group and individual mentoring sessions

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Conners' Adult ADHD Rating Scale: DSM-IV Inattention Symptom subscale
Time Frame: 4 months, 8 months, 14 months
Used to assess changes in inattention symptoms, scores range from 0-27, higher scores reflect worse functioning.
4 months, 8 months, 14 months
Conners' Adult ADHD Rating Scale: DSM-IV Hyperactive-Impulsive Symptom subscale
Time Frame: 4 months, 8 months, 14 months
Used to assess changes in hyperactive-impulsive symptoms, scores range from 0-27, higher scores reflect worse functioning.
4 months, 8 months, 14 months
Behavior Rating Inventory of Executive Function, Adult Version - Global Executive Composite subscale
Time Frame: 4 months, 8 months, 14 months
Used to assess changes in self-reported overall executive functioning, scores range from 70-210, higher scores indicate worse functioning
4 months, 8 months, 14 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
ADHD Impact Module - Adult: Performance and Daily Functioning subscale
Time Frame: 4 months, 8 months, 14 months
Used to assess changes in performance and daily functioning, scores range from 0-100, higher scores reflect better functioning.
4 months, 8 months, 14 months
ADHD Impact Module - Adult: General Well-Being subscale
Time Frame: 4 months, 8 months, 14 months
Used to assess changes in general well-being, scores range from 0-100, higher scores reflect better functioning.
4 months, 8 months, 14 months
Learning & Study Strategies Inventory: Test Strategies subscale
Time Frame: 4 months, 8 months, 14 months
Used to assess self-reported changes in academic functioning, scores range from 8-40, higher scores reflect better functioning.
4 months, 8 months, 14 months
Learning & Study Strategies Inventory: Study Aids subscale
Time Frame: 4 months, 8 months, 14 months
Used to assess self-reported changes in academic functioning, scores range from 8-40, higher scores reflect better functioning.
4 months, 8 months, 14 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Arthur D Anastopoulos, Ph.D., UNC Greensboro

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 1, 2015

Primary Completion (Actual)

December 31, 2018

Study Completion (Actual)

May 15, 2019

Study Registration Dates

First Submitted

December 2, 2019

First Submitted That Met QC Criteria

December 2, 2019

First Posted (Actual)

December 4, 2019

Study Record Updates

Last Update Posted (Actual)

December 6, 2019

Last Update Submitted That Met QC Criteria

December 4, 2019

Last Verified

December 1, 2019

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

YES

IPD Plan Description

The investigators will make de-identified data, codebooks, documentation, and research protocols available on UNCG's institutional repository, NC DOCKS (North Carolina Digital Online Collection of Knowledge and Scholarship), through the Odum Institute Data Archive. As an established and trusted repository in the social science field, the Odum Institute Data Archive is a member of the Data Preservation Alliance for the Social Sciences (Data-PASS) and the Library of Congress National Digital Stewardship Alliance (NDSA), and provides a strong archival and data distribution resource to the project. The partnership between NC DOCKS and the Odum Institute allows researchers at UNCG to upload data into the Odum Institute's Dataverse Network at no additional cost to the researcher. Data used for manuscripts accepted and published during or following the grant period will be uploaded and made available at the time the associated manuscripts are first made available by the publisher.

IPD Sharing Time Frame

The final, complete data set, including variables that may not have been used in any publications to that point, will be deposited by the project completion date, and made available within 3 years after the end of all data collection activities. All datasets will be stored in, and made available through NC DOCKS for a minimum of 10 years.

IPD Sharing Supporting Information Type

  • STUDY_PROTOCOL
  • ANALYTIC_CODE

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Attention Deficit Hyperactivity Disorder

3
Subscribe